| William Rushing Hemphill Iii, | |
|
3061 N Market Ave, Fayetteville, AR 72703-3515 | |
| (479) 444-6277 | |
| (479) 444-6278 |
| Full Name | William Rushing Hemphill Iii |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 3061 N Market Ave, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386362549 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 5150 (Arkansas) | Primary |
| Provider Name | A Yumang Rehab Serivces Pa |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1356435358 PECOS PAC ID: 1052210887 Enrollment ID: O20031231000273 |
News Archive
As brain cells age they lose the fibers that receive neural impulses, a change that may underlie cognitive decline. Researchers at the University of California, Irvine recently found a way to reverse this process in rats. The study was published February 3 in The Journal of Neuroscience. Researchers caution that more studies are needed, but the findings shed light on the mechanisms of cognitive decline and identify potential strategies to stem it.
Scientists say most people in North America are not taking enough vitamin D, and that could increase their risk for developing cancer quite significantly.
A recent study by investigators at VIB and KU Leuven has demonstrated that chloroquine also normalizes the abnormal blood vessels in tumors. This blood vessel normalization results in an increased barrier function on the one hand - thereby blocking cancer cell dissemination and metastasis - and in enhanced tumor perfusion on the other hand, which increases the response of the tumor to chemotherapy.
WMDO, the leading global provider of innovative online training for medical device professionals, and AusBiotech, Australia's leading biotechnology industry organization, announced today a strategic partnership that offers AusBiotech Members access to WMDO's professional online training.
A class of cancer drugs called PARP inhibitors could be useful for treating and preventing brain disorders, including amyotrophic lateral sclerosis, also called Lou Gehrig's disease, and some forms of frontotemporal degeneration, by halting the misplacement of specific proteins that affect nerve cells, according to a study published in Molecular Cell by researchers in the the School of Arts and Sciences and the Perelman School of Medicine at the University of Pennsylvania.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Rushing Hemphill Iii, Po Box 871, Tontitown, AR 72770-0871 Ph: (479) 444-6277 | William Rushing Hemphill Iii, 3061 N Market Ave, Fayetteville, AR 72703-3515 Ph: (479) 444-6277 |
News Archive
As brain cells age they lose the fibers that receive neural impulses, a change that may underlie cognitive decline. Researchers at the University of California, Irvine recently found a way to reverse this process in rats. The study was published February 3 in The Journal of Neuroscience. Researchers caution that more studies are needed, but the findings shed light on the mechanisms of cognitive decline and identify potential strategies to stem it.
Scientists say most people in North America are not taking enough vitamin D, and that could increase their risk for developing cancer quite significantly.
A recent study by investigators at VIB and KU Leuven has demonstrated that chloroquine also normalizes the abnormal blood vessels in tumors. This blood vessel normalization results in an increased barrier function on the one hand - thereby blocking cancer cell dissemination and metastasis - and in enhanced tumor perfusion on the other hand, which increases the response of the tumor to chemotherapy.
WMDO, the leading global provider of innovative online training for medical device professionals, and AusBiotech, Australia's leading biotechnology industry organization, announced today a strategic partnership that offers AusBiotech Members access to WMDO's professional online training.
A class of cancer drugs called PARP inhibitors could be useful for treating and preventing brain disorders, including amyotrophic lateral sclerosis, also called Lou Gehrig's disease, and some forms of frontotemporal degeneration, by halting the misplacement of specific proteins that affect nerve cells, according to a study published in Molecular Cell by researchers in the the School of Arts and Sciences and the Perelman School of Medicine at the University of Pennsylvania.
› Verified 1 days ago
Karen Hairston, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2474 E Joyce Blvd, Suite 2, Fayetteville, AR 72703 Phone: 479-521-8326 Fax: 479-521-5439 | |
Fernando Castillo, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3383 N Mana Ct Ste 201, Fayetteville, AR 72703 Phone: 479-571-6780 | |
Kymbrly Hannah, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2474 E Joyce Blvd, Suite 2, Fayetteville, AR 72703 Phone: 479-521-8326 Fax: 479-521-5439 | |
Ms. Heather Kristine Vaughn, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1125 N College Ave, Fayetteville, AR 72703 Phone: 479-713-8630 Fax: 479-713-8639 | |
Megan Landry Wilson, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1923 E Joyce Blvd, Fayetteville, AR 72703 Phone: 479-442-7220 | |
Travis Alexander, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3399 Black Forest Dr Ste 3, Fayetteville, AR 72704 Phone: 479-435-6712 Fax: 844-317-0394 | |
Winston Tyler Futrell, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2668 E Citizens Dr Ste 5, Fayetteville, AR 72703 Phone: 479-595-0711 |